Oncocross Co., Ltd.
KOE: 382150.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yi Rang Kim
- Employees
- 31
- Headquarters
- Seoul, South Korea
- IPO year
- 2024
- Market cap
- ₩92.1B
- Website
- https://www.oncocross.com
Loading 382150…
Loading profile data…Frequently asked questions about 382150
What does Oncocross Co., Ltd. (382150.KQ) do?
Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. It provides a new approach to new drug development by sharing the analysis results using AI new drug development platform. The company was founded by Yi-Rang Kim on June 22, 2015 and is headquartered in Seoul, South K...
Where does 382150.KQ trade?
Oncocross Co., Ltd. (382150.KQ) trades on the KOSDAQ.
What sector is 382150.KQ in?
Oncocross Co., Ltd. (382150.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oncocross Co., Ltd.?
Yi Rang Kim is the chief executive officer of Oncocross Co., Ltd. (382150.KQ).
Where is Oncocross Co., Ltd. headquartered?
Oncocross Co., Ltd. is headquartered in South Korea.
Does 382150.KQ pay a dividend?
Oncocross Co., Ltd. (382150.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 382150.KQ go public?
Oncocross Co., Ltd. (382150.KQ) completed its initial public offering in 2024.